Drugs / HYNR-CS-Allo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01758510 | Dec 2012 → Apr 2017 | amyotrophic lateral sclerosis | Hanyang University Seoul Hospital | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HYNR-CS-Allo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01758510 ↗ |